Which GLP-1 Is Best For Me?

What is the GLP Finder™?

The GLP Finder™ is a free, interactive educational tool from Dr. Jay's Peptides designed to help curious adults explore the rapidly evolving world of GLP-related education. It is not a diagnostic tool, a prescription tool, or a medical recommendation engine. Instead, the GLP Finder™ asks a focused series of questions about your goals, prior experience, lifestyle, and preferences, then translates those answers into educational pathway suggestions across three commonly discussed compounds: Semaglutide, Tirzepatide, and Retatrutide. By visualizing how your answers cluster around different pathways, the tool helps you have a more informed conversation with a licensed healthcare provider.

How the GLP Finder works

Each question in the GLP Finder™ contributes a small number of weighted points to one or more pathways. The questions are intentionally varied so that no single answer determines the outcome. After the final question, the tool sums the scores, applies a deterministic tie-breaker, and shows you the top educational match along with optional alternatives and a side-by-side comparison. Because all of the logic runs on your device, your answers never leave your browser unless you explicitly choose to save your results via the lead form. The educational scores shown in the Why You Matched panel — Appetite Control, Cravings & Food Noise, Metabolic Support, Lifestyle Readiness, and Weight Management Focus — are computed from the same underlying answers and exist solely to make the scoring transparent.

Understanding appetite regulation

Appetite is governed by a network of hormones, neural circuits, and behavioral cues. GLP-1 — short for glucagon-like peptide-1 — is one of the most studied of these hormones. Released by the gut in response to food intake, GLP-1 slows gastric emptying, modulates insulin release, and signals satiety to the brain. Educational tools like the GLP Finder™ make it easier to see how different GLP-related pathways are talked about in research and lay coverage, so you can frame more useful questions for your provider. Other hormones — GIP, glucagon, leptin, and ghrelin — all play roles, and the multi-pathway compounds discussed below engage with more than one of these signaling systems at once.

Understanding food noise

Food noise is the colloquial term for the constant background hum of food-related thoughts: cravings, planning the next meal, replaying what you ate, or negotiating with yourself about a snack. For many people exploring GLP-related education, the most striking change discussed in interviews and self-reports is a reduction in this mental chatter. The GLP Finder™ explicitly asks about your relationship with cravings and food noise because these answers help identify which educational pathway will be most relevant to your situation.

GLP-1 educational overview

The GLP-1 family includes single-pathway agents that act on the GLP-1 receptor and multi-pathway agents that combine GLP-1 activity with other gut hormones. Single pathway agents are the most established in the educational literature; multi-pathway agents are newer and more frequently discussed in current research. Each profile is associated with different educational conversations around appetite regulation, metabolic activity, side-effect tolerability, and body-composition outcomes.

Semaglutide educational overview

Semaglutide is a long-acting GLP-1 receptor agonist with the largest educational footprint of the three compounds covered in the GLP Finder™. Because it engages a single pathway, the science discussion around Semaglutide tends to focus on appetite regulation, satiety, and gradual metabolic effects. It is frequently described as the most familiar starting point for users who want a conservative, well-documented educational pathway and prefer simpler discussions with their provider. Read the Semaglutide encyclopedia entry for a deeper educational dive.

Tirzepatide educational overview

Tirzepatide is a dual-pathway compound that engages both the GLP-1 and GIP receptors. The educational literature often describes it as a balanced advanced option, particularly for users who have explored GLP-1-only education and want to learn more about how GIP signaling may amplify appetite and metabolic effects. Because it is newer than Semaglutide, the educational conversation tends to focus on how the dual-pathway profile changes discussions of satiety, body composition, and tolerability. Read the Tirzepatide encyclopedia entry.

Retatrutide educational overview

Retatrutide is one of the most actively discussed emerging metabolic compounds. It is described as a triple-pathway agent that engages GLP-1, GIP, and glucagon receptors. Because the glucagon arm contributes to discussions of energy expenditure and metabolic flexibility, Retatrutide is most commonly mentioned in educational material aimed at users who want to understand the cutting edge of multi-receptor research. As with all GLP-related education, anything you read about Retatrutide should be reviewed with a licensed healthcare provider before any decisions are made. Read the Retatrutide encyclopedia entry.

How to use your results

Your GLP Finder™ result is not a recommendation to take any product, peptide, or medication. It is a structured starting point for further reading and provider conversations. We strongly suggest pairing your result with broader resources such as the Peptide University learning library, the Peptide Encyclopedia™, and the Peptide Finder™ for adjacent education. If you'd like more structured support, the GLP Club™ connects members with educational resources and provider review options.

Safety, scope, and what this tool will never do

The GLP Finder™ will never diagnose a condition, prescribe a medication, or claim that one compound is universally "better" than another. It will never collect clinical information, perform a medical assessment, or replace conversations with a licensed provider. All scores, percentages, pathway cards, and comparison tables exist purely for educational framing. If anything in your results concerns you, or if you have a history that suggests you should not pursue GLP-related therapies, please prioritize provider review over any output of this tool.